CLINICAL TRIALS PROFILE FOR VITRASE
✉ Email this page to a colleague
All Clinical Trials for VITRASE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00198419 ↗ | Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) | Completed | Bausch & Lomb Incorporated | Phase 1 | 2004-03-01 | The objective of this study was to rule out a greater than 10% incidence of hypersensitivity to Vitrase following a single intradermal injection of 3 USP units Vitrase. Less than or equal to 10% hypersensitivity response was considered acceptable. |
| NCT00198458 ↗ | Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) | Completed | Bausch & Lomb Incorporated | Phase 1 | 2004-07-01 | The objective of this study was to rule out a greater than 10% incidence of hypersensitivity to Vitrase following a single intradermal injection of 3 USP units Vitrase. Less than or equal to a 10% hypersensitivity response was considered acceptable. |
| NCT00198471 ↗ | Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment | Completed | Bausch & Lomb Incorporated | Phase 2 | 2005-07-01 | The purpose of this study is to assess the efficacy of intravitreous injections of Vitrase to induce posterior vitreous detachment(PVD) in subjects with moderate to severe non-proliferative diabetic retinopathy. |
| NCT00198484 ↗ | Evaluation of Vitrase as a Spreading Agent | Completed | Bausch & Lomb Incorporated | Phase 3 | 2004-10-01 | The purpose of this study is to determine whether Vitrase (hyaluronidase for injection) is effective as a spreading agent for other injected drugs prior to ocular surgery |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VITRASE
Condition Name
Clinical Trial Locations for VITRASE
Trials by Country
Clinical Trial Progress for VITRASE
Clinical Trial Phase
Clinical Trial Sponsors for VITRASE
Sponsor Name
